Visgenx, Inc.
1Patents
1Active
1Granted
52Portfolio score
Filing activity: Aug 24, 2022 → Aug 24, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11793890B2 | ELOVL2 constructs for human gene therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.